Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-113004.58%
operating margin TTM
-92086.45%
revenue TTM
37
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -1.80 |
| peg ratio | -0.07 |
| price to book ratio | 0.86 |
| price to sales ratio | 1,055.61 |
| enterprise value multiple | -4.96 |
| price fair value | 0.86 |
profitability ratios | |
|---|---|
| gross profit margin | 100.0% |
| operating profit margin | -92086.45% |
| pretax profit margin | -122682.95% |
| net profit margin | -113004.58% |
| return on assets | -31.35% |
| return on equity | -116.86% |
| return on capital employed | -38.87% |
liquidity ratios | |
|---|---|
| current ratio | 2.87 |
| quick ratio | 2.87 |
| cash ratio | 2.85 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 5,837.50 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 5,837.50 |
| receivables turnover | 0.06 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -133.90 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.91 |
| cash per share | 22.24 |
| operating cash flow per share | -4.24 |
| free cash flow operating cash flow ratio | 0.69 |
| cash flow coverage ratios | -133.90 |
| short term coverage ratios | -133.90 |
| capital expenditure coverage ratio | -3.19 |
Frequently Asked Questions
When was the last time Kazia Therapeutics Limited (NASDAQ:KZIA) reported earnings?
Kazia Therapeutics Limited (KZIA) published its most recent earnings results on 30-03-2026.
What is Kazia Therapeutics Limited's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Kazia Therapeutics Limited (NASDAQ:KZIA)'s trailing twelve months ROE is -116.86%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Kazia Therapeutics Limited (KZIA) currently has a ROA of -31.35%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did KZIA's net profit margin stand at?
KZIA reported a profit margin of -113004.58% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is KZIA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.87 in the most recent quarter. The quick ratio stood at 2.87, with a Debt/Eq ratio of 0.00.